Navigation Links
Scientists in Hungary and Portugal get research boost

Heidelberg, 29 July 2008 Two talented life scientists will receive EMBO Installation Grants, assisting them to establish their research groups in Hungary and Portugal. These two scientists will receive funding in 2008 similar to the previous nine awardees announced in November 2007. The European Molecular Biology Organization (EMBO) introduced the scheme in 2006.

EMBO Installation Grants are awarded annually and aim to strengthen science in selected member states of the EMBC, the EMBO intergovernmental funding body. The EMBC Member States hosting the grantees generally finance the grants entirely. EMBC Member States participating in the scheme include Croatia, the Czech Republic, Estonia, Hungary, Poland, Portugal and Turkey.

Each scientist receives 50,000 euro annually for three to five years to help them establish their groups and themselves in the European scientific community. Grantees are integrated into the prestigious EMBO Young Investigator network, providing networking opportunities with some of Europe's best young group leaders and a range of career development programmes.

"EMBO congratulates these two scientists as recipients of the 2007 EMBO Installation Grants and welcomes them to the EMBO community," said Hermann Bujard, EMBO Executive Director. "These talented scientists will benefit from the secure financial backing of their host countries plus the active interest and support of EMBO in their scientific and professional development. They represent a promising scientific future for the countries receiving them and for Europe as a whole."

A committee of EMBO Members selected the successful candidates for the high standard of their research. By bringing this level of scientific talent into the participating countries, EMBO hopes to improve the competitiveness of these countries in European science.

Gergely Szakcs is moving from the USA to set up his laboratory at the Hungarian Academy of Sciences in Budapest, Hungary to research multidrug resistance in cancer. Szakcs is the third awardee to establish a lab in Hungary of the total 11 scientists receiving the 2007 EMBO Installation Grants.

In Portugal, Monica Bettencourt-Dias's group is researching cell cycle links to cancer at the Gulbenkian Institute in Oeiras. Bettencourt-Dias moves from the UK and is the second awardee to set up in Portugal of the 11 grantees for 2007. Portugal's Foundation for Science & Technology (FCT) and the Gulbenkian Institute will share payment of the Dias grant. Recipients of the 2008 EMBO Installation Grants will be announced in November 2008.


Contact: Suzanne Beveridge
European Molecular Biology Organization

Related biology news :

1. Scientists break record by finding northernmost hydrothermal vent field
2. Scientists suspect omega-3 fatty acids could slow acute wound healing
3. Durham scientists to tackle CO2 storage in global warming challenge
4. Licking your wounds: Scientists isolate compound in human saliva that speeds wound healing
5. Training future scientists at the Ecological Society of Americas 93rd Annual Meeting
6. Gladstone scientists create Wikipathways to foster research collaboration
7. Nature publishes new evidence about the deep biosphere written by biogeoscientists
8. ASBMB taps 8 scientists for top awards
9. When fish talk, scientists listen
10. Scientists demonstrate the sharpest measurement of ice crystals in clouds
11. Scientists demonstrate means of reducing Alzheimers-like plaques in fly brain
Post Your Comments:
(Date:11/11/2015)... , Nov. 11, 2015   MedNet Solutions , ... spectrum of clinical research, is pleased to announce that it ... Clinical Trials (PCT) event, to be held November 17-19 ... able to view live demonstrations of iMedNet ... learn how iMedNet has been able to deliver ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, December ... Helen Torley , president and CEO, will provide a corporate overview. ... New York at 1:00 p.m. ET/10:00 a.m. PT . ... investor relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology: